Aspergillus fumigatus-Related Species in Clinical Practice

Area of Science:

• Medical Mycology
• Clinical Microbiology
• Infectious Diseases

Background:

• Aspergillus fumigatus is the primary cause of invasive aspergillosis (IA).
• Related species within the Aspergillus Fumigati section are often misidentified, leading to treatment challenges.
• These cryptic species can exhibit intrinsic resistance to antifungal drugs, complicating patient management.

Purpose of the Study:

• To highlight the diagnostic challenges posed by cryptic Aspergillus species within the Fumigati section.
• To emphasize the clinical significance of misidentification, particularly regarding antifungal resistance.
• To discuss potential methods for improved identification and management of IA caused by these species.

Main Methods:

• Review of current diagnostic limitations for distinguishing A. fumigatus from related species.
• Discussion of clinical characteristics and antifungal susceptibility profiles associated with cryptic species.
• Evaluation of emerging diagnostic technologies like multiplex PCR and MALDI-TOF MS.

Main Results:

• Cryptic species (e.g., A. lentulus, A. udagawae) are frequently misidentified using standard methods.
• These species often display resistance to azoles and other antifungals.
• Multiplex PCR and MALDI-TOF MS show promise for accurate and rapid differentiation.

Conclusions:

• Accurate identification of Aspergillus species in IA is critical due to varying antifungal susceptibilities.
• Simple clinical observations like poor sporulation or unusual susceptibility can raise suspicion for cryptic species.
• Advanced molecular and mass spectrometry techniques are needed for definitive diagnosis and improved patient outcomes in invasive aspergillosis.